Qingdao Baheal Medical Inc

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

0.90

Vol. 1Y

—

Shs. 5Y

0.31%

Rev. 5Y

1.35%

Div Yld LY

—

Div Yld TTM

—

Revenues

7.51b

-7.26%

Net income

475m

-31.36%

CFO

934m

+14.82%

Dividend

Jun 01, 20260.571 /sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Qingdao Baheal Medical Inc., established in 2005 and headquartered in Qingdao, China, operates as a pharmaceutical company. The firm's activities encompass the entire spectrum of drug development, from initial research to manufacturing and sales of various medicinal products. A key offering in its portfolio is vitamin D calcium in chewable tablet form.

URL

http://www.baheal.cn/

IPO date

Jun 30, 2021

Employees

Domiciled in

Incorporated in

Headquarters & legal address

山东省青岛市市北区开封路88号
青岛市, SD 250000
CN

Valuation

Latest on right Latest on left

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2022‑00	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT